RxDoctor Payments Data

Alan Sonsky, MD

Gastroenterology · The Villages, FLNPI 1083723225

Payments from drug & device makers

$578in general payments, 2019–2025

Across 34 payments — averaging $17.00 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$386
  • Pfizer$50
  • Takeda Pharmaceuticals U.S.A., Inc.$49
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$29
  • Nestle Healthcare Nutrition Inc.$25
  • Echosens North America, Inc.$18
  • plus $20 from 2 others

What the payments were for

  • Food & beverage$52891%
  • Education$509%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$578 in reported general payments places this provider in the 15th percentile of 1,388 gastroenterology providers in Florida.

See all gastroenterology providers in Florida

Medicare billing

Part B allowed, 2024
$33,348
Medicare patients
116
Services billed
254

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
StelaraUstekinumab11$301,393
ZenpepLipase/Protease/Amylase38$108,476
CreonLipase/Protease/Amylase33$80,597
LinzessLinaclotide69$56,154
Mesalamine48$19,889
Sucralfate142$8,323
Famotidine209$5,521
Dexlansoprazole DrDexlansoprazole24$5,154
Omeprazole145$4,329
Pantoprazole Sodium431$4,238
Budesonide DrBudesonide29$3,460
Colesevelam Hcl24$3,001
Nortriptyline Hcl111$2,320
Sod Sulf-Potass Sulf-Mag SulfSodium, Potassium,mag Sulfates24$1,312
Ondansetron OdtOndansetron28$1,271

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieCreon, Linzess$386$136,751102 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 15th percentile of 1,388 gastroenterology providers in Florida.

Other gastroenterology in The Villages

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →